Delays in protease inhibitor use in clinical practice
- 1 July 1999
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 14 (7), 395-401
- https://doi.org/10.1046/j.1525-1497.1999.08198.x
Abstract
OBJECTIVE: To determine the clinical factors associated with delayed protease inhibitor initiation. DESIGN: Chart reviewKeywords
This publication has 26 references indexed in Scilit:
- Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosisAIDS, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Antiretroviral Therapy for HIV Infection in 1997JAMA, 1997
- HIV-1 Protease InhibitorsJAMA, 1997
- Antiretroviral Therapy for HIV Infection in 1996JAMA, 1996
- Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing complianceAIDS Care, 1996
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.Proceedings of the National Academy of Sciences, 1995
- Quantitation of HIV-1 RNA in Plasma Predicts Outcome after SeroconversionAnnals of Internal Medicine, 1995
- On the mechanics of the modern working-recurve bowComputational Mechanics, 1991